Clinical Trial

Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
In this study, it was aimed to compare the multimodal analgesia application or the pericapsular nerve group (PENG) block methods in patients undergoing hip surgery. The effectiveness and benefit rate of the PENG block in postoperative pain will be evaluated. Postoperative pain, need for additional analgesia, range of motion of the hip joint, mobilization time, length of hospital time and adverse events in patients undergoing hip fracture surgery with and without PENG block will be investigated.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2023-12-13; most recent amendment 2025-11-16.
Trial Details
NCT Number NCT06183541
Lead Sponsor Umraniye Education and Research Hospital
Conditions Hip Fractures, Pain, Postoperative
Enrollment 70 participants
Start Date 2023-11-21
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-19